Tiagabine

Author:

Abstract
Summary: Tiagabine (TGB), a specific γ‐aminobutyric acid (GABA)‐uptake inhibitor, is a potential new antiepileptic drug with a novel mechanism of action. In animal models of epilepsy as well as in a placebo‐controlled trial in patients with complex partial seizures, TGB showed significant anticonvulsant effects. TGB was well tolerated by most patients.